Trademark Overview
On Monday, February 7, 2022, a trademark application was filed for EMBRYLL with the United States Patent and Trademark Office. The USPTO has given the EMBRYLL trademark a serial number of 97256428. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 5, 2023. This trademark is owned by Embryll Life Sciences, Inc.. The EMBRYLL trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations incorporating cloned embryonic cells derived by somatic cell nuclear transfer for the purpose of rejuvenation; Veterinary pharmaceutical preparations incorporating cloned embryonic cells derived by somatic cell nuclear transfer for the purpose of rejuvenation; Pharmaceutical preparations incorporating cloned embryonic cells derived by somatic cell nuclear transfer for use in regenerative medicine; Veterinary pharmaceutical preparations incorporating cloned embryonic cells derived by somatic cell nuclear transfer for use in veterinary regenerative medicine; Cloned embryonic cells derived by somatic cell nuclear transfer for medical and veterinary purposes
Medical transplant services using cloned embryonic cells derived by somatic cell nuclear transfer; Veterinary transplant services using cloned embryonic cells derived by somatic cell nuclear transfer; Production of cloned embryonic cells derived by somatic cell nuclear transfer for medical transplant; Production of cloned embryonic cells derived by somatic cell nuclear transfer for veterinary transplant; Medical clinics for purposes of transplanting cloned embryonic cells derived by somatic cell nuclear transfer; Veterinary clinics for purposes of transplanting cloned embryonic cells derived by somatic cell nuclear transfer